Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study

BACKGROUND: Multidrug-resistant Pseudomonas aeruginosa infections remain common in hospitals worldwide. We investigated the outcomes associated with the use of ceftolozane-tazobactam for the treatment of these infections. METHODS: Data were collected retrospectively from 20 hospitals across the Unit...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallagher, Jason C, Satlin, Michael J, Elabor, Abdulrahman, Saraiya, Nidhi, McCreary, Erin K, Molnar, Esther, El-Beyrouty, Claudine, Jones, Bruce M, Dixit, Deepali, Heil, Emily L, Claeys, Kimberly C, Hiles, Jon, Vyas, Nikunj M, Bland, Christopher M, Suh, Jin, Biason, Kenneth, McCoy, Dorothy, King, Madeline A, Richards, Lynette, Harrington, Nicole, Guo, Yi, Chaudhry, Saira, Lu, Xiaoning, Yu, Daohai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247659/
https://www.ncbi.nlm.nih.gov/pubmed/30488041
http://dx.doi.org/10.1093/ofid/ofy280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247659/
https://www.ncbi.nlm.nih.gov/pubmed/30488041
http://dx.doi.org/10.1093/ofid/ofy280

Ejemplares similares